Also in the EL4 lymphoma model, the IL-12 pre-post and post-only groups yielded statistically significant differences in platelet counts as compared to G-CSF on days 4, 7 and 8 post-chemotherapy (See supplemental Table 6). The gene discussed is CSF3; the disease is lymphoma.